Skip to main content
Clinical Trials/NCT03011229
NCT03011229
Withdrawn
Not Applicable

Endoscopic Ultrasound Fine Needle Biopsy of Submucosal Lesions of the GI Tract; Finding the Right Needle - A Randomized Study

Duke University1 site in 1 countrySeptember 5, 2017
ConditionsGI Lesions

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
GI Lesions
Sponsor
Duke University
Locations
1
Primary Endpoint
diagnostic accuracy of biopsy needle
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to compare the diagnostic accuracy of a novel endoscopic ultrasound (EUS) biopsy needle to the current standard EUS needle.

The investigators hypothesize that with the SharkcoreTM needle a diagnostic yield of 90% is possible for subepithelial lesions (SEL) within the Gastrointestinal (GI) tract versus 60% yield with the current needle.

Registry
clinicaltrials.gov
Start Date
September 5, 2017
End Date
September 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients age 18 or older referred for EUS found to have a hypoechoic lesion \> 8 mm within the GI lumen arising from the muscularis propria, as determined by EUS.
  • Women that have a negative pregnant test

Exclusion Criteria

  • Patients under the age of
  • Uncorrectable coagulopathy (INR\>1.5)
  • Uncorrectable thrombocytopenia (platelet count \<50,000)
  • Patient who is unable to comply with study requirements
  • Pregnant women
  • Female patients who are not tested per our current unit protocol
  • Refusal to consent or unable to provide informed consent

Outcomes

Primary Outcomes

diagnostic accuracy of biopsy needle

Time Frame: end of biopsy, approximately 10 minutes

Study Sites (1)

Loading locations...

Similar Trials